Sana Biotechnology, Inc. Balance Sheet
SANA / Health Care|6 years of annual SEC 10-K data (FY2019-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Sana Biotechnology, Inc. had $501M in total assets and $251M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $127.6M | $133.5M | $176.8M | $253.0M | $124.8M | - |
| Current Assets | $160.8M | $213.5M | $444.4M | $558.1M | $384.5M | - |
| PP&E (Net) | $77.3M | $70.7M | $66.9M | $65.5M | $46.8M | - |
| Goodwill | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | - |
| Total Assets | $501.0M | $565.3M | $822.7M | $1.1B | $730.3M | - |
| Current Liabilities | $45.4M | $64.5M | $111.5M | $99.2M | $31.5M | - |
| Shareholders' Equity | $250.5M | $287.5M | $499.3M | $728.5M | -$421.2M | -$142.5M |